Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025
Novavax (Nasdaq: NVAX) has scheduled its second quarter 2025 financial results and operational highlights conference call for August 6, 2025, at 8:30 a.m. ET. The company will host a conference call with both domestic and international dial-in options, and participants can register online for automated callback access.
A replay of the conference call will be available from 11:30 a.m. ET on August 6 until August 13, 2025. The webcast replay will remain accessible on the company's investor relations website until September 5, 2025.
Novavax (Nasdaq: NVAX) ha programmato la conferenza telefonica per la presentazione dei risultati finanziari e degli aggiornamenti operativi del secondo trimestre 2025 per il 6 agosto 2025 alle 8:30 a.m. ET. La società organizzerà una chiamata con opzioni di accesso sia nazionali che internazionali, e i partecipanti potranno registrarsi online per ricevere una richiamata automatica.
La registrazione della conferenza telefonica sarà disponibile dalle 11:30 a.m. ET del 6 agosto fino al 13 agosto 2025. La replica via webcast resterà accessibile sul sito web delle relazioni con gli investitori della società fino al 5 settembre 2025.
Novavax (Nasdaq: NVAX) ha programado su llamada de conferencia para los resultados financieros y aspectos operativos del segundo trimestre de 2025 para el 6 de agosto de 2025 a las 8:30 a.m. ET. La empresa ofrecerá una llamada con opciones de marcación tanto nacionales como internacionales, y los participantes podrán registrarse en línea para recibir una llamada automática de retorno.
La repetición de la llamada estará disponible desde las 11:30 a.m. ET del 6 de agosto hasta el 13 de agosto de 2025. La repetición en webcast permanecerá accesible en el sitio web de relaciones con inversionistas de la compañía hasta el 5 de septiembre de 2025.
노바백스(Nasdaq: NVAX)는 2025년 2분기 재무 실적 및 운영 현황 컨퍼런스 콜을 2025년 8월 6일 오전 8시 30분(동부 표준시)에 예정했습니다. 회사는 국내외 전화 접속 옵션을 제공하며, 참가자는 자동 콜백을 위한 온라인 등록이 가능합니다.
컨퍼런스 콜 녹음은 2025년 8월 6일 오전 11시 30분(동부 표준시)부터 2025년 8월 13일까지 이용할 수 있습니다. 웹캐스트 녹음은 회사 투자자 관계 웹사이트에서 2025년 9월 5일까지 계속 접속할 수 있습니다.
Novavax (Nasdaq : NVAX) a programmé sa conférence téléphonique sur les résultats financiers et les faits marquants opérationnels du deuxième trimestre 2025 pour le 6 août 2025 à 8h30 (heure de l’Est). La société organisera une conférence téléphonique avec des options d’appel nationales et internationales, et les participants pourront s’inscrire en ligne pour recevoir un rappel automatique.
Un replay de la conférence téléphonique sera disponible du 6 août 2025 à 11h30 (heure de l’Est) jusqu’au 13 août 2025. La rediffusion en webcast restera accessible sur le site des relations investisseurs de la société jusqu’au 5 septembre 2025.
Novavax (Nasdaq: NVAX) hat seine Telefonkonferenz zu den Finanzergebnissen und betrieblichen Highlights des zweiten Quartals 2025 für den 6. August 2025 um 8:30 Uhr ET angesetzt. Das Unternehmen wird eine Telefonkonferenz mit nationalen und internationalen Einwahlnummern veranstalten, und Teilnehmer können sich online registrieren, um einen automatischen Rückruf zu erhalten.
Eine Aufzeichnung der Telefonkonferenz wird vom 6. August 2025 um 11:30 Uhr ET bis zum 13. August 2025 verfügbar sein. Die Webcast-Wiedergabe bleibt bis zum 5. September 2025 auf der Investor-Relations-Website des Unternehmens zugänglich.
- None.
- None.
Conference call details: | |
Date: | August 6, 2025 |
Time: | 8:30 a.m. |
URL to register phone: | |
Dial-in number: | (888) 880-3330 (Domestic) or |
(+1) (646) 357-8766 (International) | |
Webcast: |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.
Replay details: | |
Date: | Available starting at 11:30 a.m. |
Dial-in number: | (800) 770-2030 (Domestic) or |
(+1) (609) 800-9909 (International) | |
Passcode: | 3041984# |
Webcast: | ir.novavax.com/events, until September 5, 2025 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-second-quarter-2025-financial-results-on-august-6-2025-302516855.html
SOURCE Novavax, Inc.
FAQ
When will Novavax (NVAX) report Q2 2025 earnings?
How can investors access Novavax's Q2 2025 earnings call?
How long will Novavax's Q2 2025 earnings call replay be available?
What is the passcode for Novavax's Q2 2025 earnings call replay?
